Which depressed patients respond to nefazodone and when?

Journal of Clinical Psychiatry

Volumn 62, Issue 3, 2001, Pages 158-163

  Trivedi, M H ^a   Rush, A J ^a   Pan, J Y ^a   Carmody, T J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NEFAZODONE; PAROXETINE; PLACEBO; SERTRALINE;

ACUTE DISEASE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REMISSION; RETROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0035057636     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0304     Document Type: Article

References (46)

1. Antidepressant and antimanic medications
2. Selection of an antidepressant: Mirtazapine
3. Treatment of refractory depression
4. Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates
5. Antidepressants
6. Response and discontinuation rates of newer antidepressants: A meta-analysis of randomized controlled trials in treating depression
7. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline
8. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
9. Response to an open trial of a second SSRI in major depression
10. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
11. When at first you don't succeed: Sequential strategies for antidepressant nonresponders
12. Texas Medication Algorithm Project: Definitions, rationale, and methods to develop medication algorithms
13. Consensus guidelines in the treatment of major depressive disorder
14. Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project
15. Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP)
16. The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder
17. Nefazodone: A review of its pharmacology and clinical efficacy in the management of major depression
18. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
19. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
20. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week, clinical trial
21. A double-blind comparison of nefazodone, imipramine, and placebo in major depression
22. Nefazodone and imipramine in major depression: A placebo-controlled trial
23. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
24. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression
25. Paroxetine: An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders
26. From scientific knowledge to the clinical practice of psychopharmacology: Can the gap be bridged?
27. Strategies and tactics in the treatment of depression
28. Treating depression to remission
29. The Structured Clinical Interview for DSM-III-R (SCID), 1: History, rationale, and description
30. A rating scale for depression
31. Development of a rating scale for primary depressive illness
32. The Inventory of Depressive Symptomatology (DS): Preliminary findings
33. The Inventory of Depressive Symptomatology (IDS): Psychometric properties
34. The assessment of anxiety states by rating
35. When do patients respond to tricyclic antidepressants?
36. Non-parametric estimation from incomplete observations
37. What constitutes an adequate antidepressant trial for fluoxetine?
38. Delayed onset of action of antidepressant drugs? survey of results of Zurich meta-analyses
39. The treatment of chronic depression, pt 2: A double-blind, randomized trial of sertraline and imipramine
40. Identification of true drug response to antidepressants
41. Use of pattern analysis to identify true drug response
42. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
43. Timing of onset of antidepressant response with fluoxetine treatment